Not everything in biotech has taken a hit this year. Jim Cramer spoke with…
Tag:
Pharmaceuticals
-
-
This under-the-radar biotech roared nearly 10 percent on news of its Phase 3 study.…
-
With a host of new drugs in development, and a skyrocketing stock, can it…
-
Jim Cramer speaks with the CEO of a stock that is absolutely blazing on…
-
If you put ten thousand dollars in Regeneron 10 years ago, you’d be a…
Newer Posts